Articles by tag: metabolic-inhibitors

Lymphoma metabolism: new vulnerabilities for CAR-T therapy

Nature reveals metabolic subtypes of DLBCL. Learn how glycolysis and lipid inhibitors enhance CAR-T efficacy. Read market forecast until 2028.